does pfizer make a glp-1 While Lilly and Novo dominate today's $50B+ obesity market, is preparing killer portfolio to steal the spotlight in 2030s China Opens Its Weight-Loss Drug

[DOI] [PubMed] [Google Scholar] 122.Balantekin K.N., Kretz M.J., Mietlicki-Baase E.G

Clinical research reveals GLP-1s offer far-reaching benefits: cardiovascular protection, improved insulin sensitivity, reduced inflammation, and potential neuroprotective effects

One consequence of this popularity is that despite their high cost, the GLP-1 agonist medications have seen demand outstrip their supply resulting in shortages making their availability to treat diabetes more limited

The most commonly discussed side effects of GLP-1 receptor agonists are nausea and vomiting, which are especially prominent when starting the medication or when the dose is increased

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome